Market News Today — AI-Curated Stock & Crypto Headlines

The Food and Drug Administration has recorded two ‘serious’ cases in patients taking Eli Lilly’s weight-loss pill.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

TransMedics Group's medical stock is nearing a buy point due to robust demand for its technology and services, particularly in liver transplants, driven by FDA approval of its Organ Care System platform.

Moderna's stock rises after the FDA announces it will review the company's seasonal flu vaccine candidate, a reversal from its earlier rejection.

Moderna's stock has declined due to the FDA's rejection of its application for a new seasonal flu vaccine, leaving investors puzzled about the reason behind the decision.

Hims & Hers Health stock dropped 16% after facing a lawsuit from Novo Nordisk and FDA scrutiny, impacting investor sentiment.

Hims & Hers has abandoned its weight-loss drug due to a potential patent infringement issue with Novo Nordisk's Wegovy, following an FDA probe.